Mitsotakis at New Pharmaceutical Hub in Tripoli: ‘Investments Once Seemed Like Science Fiction’

—

in

Prime Minister Kyriakos Mitsotakis visited the new pharmaceutical manufacturing facilities in Tripoli on Tuesday, 28 April 2026 — a major hub for Greek pharmaceutical companies aiming to strengthen domestic drug production, meet critical healthcare needs, and create new jobs. Accompanied by Health Minister Adonis Georgiadis, Theodoros Tryfon, President of the Hellenic Association of Pharmaceutical Companies (PEF), and Dimitrios Demo, PEF Vice President, Mitsotakis toured the newly established production units of DEMO, WIN MEDICA, and FARAN.

Over 1,500 Jobs and Regional Revitalization

The three projects are expected to generate more than 1,500 direct and indirect jobs, boosting the local economy of Arcadia and the Peloponnese while helping retain young scientists in Greece.

‘A Scenario from Science Fiction’

After the tour, Mitsotakis described the development as something that would have seemed unimaginable just a few years ago. “What we’re seeing here in Tripoli today — something that, if discussed a few years ago, would have sounded like a science fiction scenario — has now become reality,” he said.

He commended the Greek pharmaceutical firms for choosing Tripoli and leveraging government investment incentives to build innovative, high-tech production units. “We’ve proven that regional development and productive transformation can indeed become reality,” he added, highlighting the shift toward high-value-added sectors outside Athens.

Strategic Autonomy for Greece and Europe

Mitsotakis linked the investments to broader European discussions on strategic autonomy, stressing that Tripoli will produce a significant share of medicines serving not only Greek but also wider European needs. “For us, the export-oriented pharmaceutical industry is a flagship sector — one the Greek government will continue to support robustly,” he stated, calling it a “high-value-added” and “strategically autonomous” industry.

He also reaffirmed the government’s commitment to the clawback mechanism — a tool used to adjust pharmaceutical pricing — saying it will be maintained and strengthened “within available capacities.”

New Jobs, Higher Wages, Better Quality of Life

Mitsotakis emphasized how these investments offer a new professional horizon for young people in Arcadia and the Peloponnese. The jobs being created come with salaries “significantly above the national average,” in a modern, high-standard work environment — all combined with the quality of life offered by Greece’s regions.

“When someone can combine living in provincial Greece with a well-paid, high-skilled job, we truly understand how attractive decentralization can become,” he noted.

Georgiadis: ‘The Largest Productive Model Shift’

Health Minister Adonis Georgiadis described the initiative as “the largest shift in Greece’s productive model” — underscoring its long-term impact on public health resilience, industrial policy, and regional equity.